The company is seeking to raise additional funding. Genomind, area Acme parent partner to up awareness of genetic tes Montco firm introduces its latest genetic mental health tool Montco firm ...

GLEN ALLEN, Va., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the ...

Expanded testing panel provides a better understanding of a patient’s genetic medication risk profile. Genomind’s real-time, interactive, medication management tool GenMedPro™ has expanded to include ...

PHILADELPHIA--(BUSINESS WIRE)-- Audacy announced a multiplatform partnership with mental health innovator Genomind. This breakthrough partnership taps into Audacy’s influencers and Genomind’s ...

KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Genomind®, the leader in comprehensive genetics and digital mental health services, has pioneered a new level of specificity and accuracy for cheek swab-based ...

Genomind’s pharmacogenetic testing, which is transforming the landscape of precision medicine, uses a simple cheek swab to assess genes that influence drug metabolism, tolerability, and efficacy. The ...

Partnership has successfully completed analytical validation of a cheek swab collection solution for testing and identifying patients with the genotypes important for AD04 development GLEN ALLEN, Va., ...